Biotechnology Stocks I Performance Guide: Crinetics Pharmaceuticals, Inc. (CRNX)
CRNX has no dividends
Table and Chart of CRNX Performance
See what a $1,000 investment in CRNX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CRNX Returns | |
|---|---|
| Start Date | Aug-31-2018 |
| Start Price | $29.99 |
| End Date | Dec-01-2023 |
| End Price | $32.74 |
| # Prices | 65 |
| Min Date | Oct-30-2020 |
| Min Price | $12.08 |
| Max Date | Nov-30-2018 |
| Max Price | $34.94 |
| Total Return | 9.17% |
| Annualized Return | 1.63% |
| Current Value of $1,000 Purchase | $1,092 |
| Number Returns | 2,080 |
| Average Return | 4.05% |
| Number Profitable Returns | 1,001 |
| Percent Profitable Returns | 48.13% |
| Number Unprofitable Returns | 1,079 |
| Percent Unprofitable Returns | 51.88% |
| Profitable to Unprofitable Returns Ratio | 0.93 |
| CRNX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,187,009,000 | Price to Sales | 463.15 |
| Earnings per Share | $-3.6400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.993 |
| PRICE DATA | |
| 52 Week High | $33.2 |
| 52 Week Low | $15.23 |
| Analyst Target Price | $46.82 |
| 50-Day Moving Average | $28.98 |
| 200-Day Moving Average | $21.82 |
| FINANCIAL DATA | |
| Revenue per Share | $0.086 |
| Revenue | $4,722,000 |
| Profit Margin | 0% |
| Return on Equity | -0.444% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CRNX Compare Returns with S&P 500
CRNX Trendline Chart